In order to further promote the implementation of the pharmaceutical enterprise ethics standards "(hereinafter referred to as the" code of ethics "), to strengthen the construction of industry credit system, actively practice self-discipline, to create a fair and orderly competition environment and industry management platform itself, following the October 29, 2013, "China pharmaceutical enterprise ethics release conference", by China pharmaceutical industry association, Chinese medicine and health products import and export chamber of commerce, China council for the promotion of pharmaceutical industry research and development, China association of enterprises with foreign investment in drug research and development industry committee (RDPAC), China association of traditional Chinese medicine, Chinese medicine business association, China association of OTC medications, China council for the promotion of development of pharmaceutical enterprises and the Chinese medical association of enterprise culture construction plan nine medical association chamber of commerce hosted "pharmaceutical enterprise ethics BBS in China" was held in Beijing friendship hotel on May 27 2014. 

China food and drug administration , the state of health and family planning commission, the state administration of traditional Chinese medicine, industry and information technology ministry leaders attended the meeting..From the domestic and foreign pharmaceutical industry association, society, representing 65 companies and major medical news media on behalf of a total of more than 130 people attended the meeting. BBS by the China pharmaceutical industry association executive vice President of Pan Guangcheng host.